Artal Group S.A.
CIK 1053906 · Holdings on Sep 30, 2023 · First reported Nov 13, 2023
Top ten holdings
Q3 2023- CAVA42.74%
- LXRX5.59%
- MRTX3.84%
- ONC3.17%
- RVMD3.05%
- SRRK2.80%
- APLS2.76%
- 03152W1092.15%
- MORF2.14%
- CYTK1.95%
Share classes counted separately70.19%
Portfolio value by quarter
Top 10 holdings 27
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | CAVACAVA GROUP INC View history and evidence | $980.40M | 42.74% | 32.01M shares | — | ↗▾ | |
| 02 | LXRXLEXICON PHARMACEUTICALS INCCOM NEW View history and evidence | $128.13M | 5.59% | 117.55M shares | — | ↗▾ | |
| 03 | MRTXMIRATI THERAPEUTICS INC View history and evidence | $88.17M | 3.84% | 2.02M shares | — | ↗▾ | |
| 04 | ONCBEONE MEDICINES LTD-ADRSPONSORED ADR View history and evidence | $72.66M | 3.17% | 403.93K shares | — | ↗▾ | |
| 05 | RVMDREVOLUTION MEDICINES INC View history and evidence | $70.02M | 3.05% | 2.53M shares | — | ↗▾ | |
| 06 | SRRKSCHOLAR ROCK HOLDING CORP View history and evidence | $64.32M | 2.80% | 9.06M shares | — | ↗▾ | |
| 07 | APLSAPELLIS PHARMACEUTICALS INC View history and evidence | $63.32M | 2.76% | 1.66M shares | — | ↗▾ | |
| 08 | 03152W109AMICUS THERAPEUTICS INC View history and evidence | $49.40M | 2.15% | 4.06M shares | — | ↗▾ | |
| 09 | MORFMORPHIC HOLDING INC View history and evidence | $48.99M | 2.14% | 2.14M shares | — | ↗▾ | |
| 10 | CYTKCYTOKINETICS INCCOM NEW View history and evidence | $44.74M | 1.95% | 1.52M shares | — | ↗▾ |
Options overlay 3
$38.44M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
MRTXMIRATI THERAPEUTICS INC View history and evidence | Call | 700.00K | $30.49M | ▾ | |
03152W109AMICUS THERAPEUTICS INC View history and evidence | Call | 500.00K | $6.08M | ▾ | |
PYPLPAYPAL HOLDINGS INC View history and evidence | Call | 32.00K | $1.87M | ▾ |
3 / 3 options · preview only
Exited positions 23
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| XBI SS SPDR S&P BIOTECH ETF | Call | — | — | SEC filing ↗ | |
| KRYS KRYSTAL BIOTECH INC | Non-derivative | — | — | SEC filing ↗ | |
| SAGE SAGE THERAPEUTICS INC | Non-derivative | — | — | SEC filing ↗ |
3 / 23 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1053906 · Period 2023-09-30
Data loaded 2026-09-23 · First reported 2023-11-13
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 2332347
}Research all 104 reported holdings.
This page includes 30 of 104 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 104 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1053906","quarter":"2023Q3","page_size":100}
get_institutional_manager_history
{"cik":"1053906","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.